Table 1.

Correlation between KAI1 and vimentin and E-cad expression to clinicopathological characteristics in 312 NSCLC patients

Variable	KAI1		P value	E-cadherin		P value	Vimentin		P value
	(−)	(+)		(−)	(+)		(−)	(+)
Ages			0.622			0.894			0.336
<60	95	52		88	59		89	58
≥60	111	54		100	65		91	74
Gender			0.038			0.423			0.597
Male	147	87		138	96		137	97
Female	59	19		50	28		43	35
Diameter			0.081			0.070			0.368
<3.0 cm	32	9		30	11		21	20
≥3.0 cm	174	97		158	113		159	112
Histology			0.283			0.077			0.323
SCC	155	79		144	90		137	97
Adenocarcinoma	43	26		36	33		40	29
LCC	8	1		8	1		3	6
Smoking			0.957			0.791			0.185
Yes	151	78		139	90		127	102
No	55	28		49	34		53	30
Grades of tumor			<0.001			<0.001			0.002
Well	10	31		13	28		32	9
Moderately	135	68		116	87		118	85
Poorly	61	7		59	9		30	38
TNM stages			<0.001			<0.001			<0.001
I	10	57		7	60		65	2
II	85	35		77	43		89	31
III	111	14		104	21		26	99
VI			<0.001			<0.001			<0.001
Yes	42	1		40	3		5	38
No	164	105		148	121		175	94
Marginal free			0.119			0.085			<0.001
Yes	171	95		155	111		167	99
No	35	11		33	13		13	33

NSCLC non-small cell lung cancer, SCC squamous cell carcinoma, LCC large cell carcinoma, VI vascular invasion